Ian Mortimer Xenon Pharmaceuticals Inc. (XENE) insider trading activity
Ian Mortimer is PRESIDENT & CEO of Xenon Pharmaceuticals Inc.. Currently has a direct ownership of 31,302 shares of XENE, which is worth approximately $1.21 Million. The most recent transaction as insider was on May 24, 2023, when has been sold 31,655 shares (Common Shares) at a price of $41.43 per share, resulting in proceeds of $1,311,466. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
31.3K
0%
3M change
0%
12M change
Total Value Held
$1.21 Million
IAN MORTIMER Transaction History
IM
Ian Mortimer
PRESIDENT & CEO
Burnaby, A1